{
  "docId": "019de070-a7f9-700d-9686-c0d9e2559ea7",
  "docSlug": "49e1302a11c2e640ac427a516c932653",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 82 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 48,
  "pageCount": 82,
  "prevPage": 47,
  "nextPage": 49,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 48,
  "notes": "Includes non-GAAP metrics like EBITA and organic growth; highlights LOE revenue drag.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-a7f9-700d-9686-c0d9e2559ea7/48",
  "deckHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7",
  "deckJsonHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7.json",
  "deckAnchorHref": "/decks/019de070-a7f9-700d-9686-c0d9e2559ea7#slide-48",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.235,
        "x": 0.755,
        "y": 0.175
      },
      "kind": "callout",
      "text": "+29% Global Solta organic revenue growth vs. YTD19, driven by continued strong demand of Thermage FLX. FY20, Ortho Dermatologics business unit had an LOE revenue drag of $37M; LOE was primarily ELIDEL and ZOVIRAX.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11ab0ada-342d-4f50-af7d-477a79bcc5a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.72,
        "x": 0.268,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "1. See Slide 2 and Appendix for further non-GAAP information. 2. See Appendix for further information on the use and calculation of constant currency. 3. Organic growth/change, a non-GAAP metric, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations. 4. See the Appendix for details on amortization and impairments of intangible assets.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da88c463-a627-4993-8b46-dd1f42de8b80",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.655,
        "w": 0.698,
        "x": 0.033,
        "y": 0.16
      },
      "kind": "table",
      "text": "Financial performance table with columns for 12.31.20, 12.31.19, Reported, Constant Currency, and Organic Change.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7bdbd0c4-d93b-4079-aad5-9d8d19c6506f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.375,
        "x": 0.201,
        "y": 0.065
      },
      "kind": "title",
      "text": "Financial Results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd018c8c-bbd8-4879-b716-c0521c4a2f42",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}